NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Gene Therapy



Research in the area of cancer gene therapy reported from M.E. Mossoba and colleagues



May 28th, 2008

According to a study from Toronto, Canada, "Gene therapy strategies may accelerate the development of prophylactic immunotherapy against cancer. We synthesized a lentiviral (LV) vector encoding a kinase-deficient form of erbB2 ( erbB2tr) to transduce murine dendritic cells (DCs) efficiently."

"Murine erbB2 models a clinically relevant tumor-associated self-antigen; its human homolog ( HER-2/neu) is overexpressed in breast cancer and in 80% of metastatic prostate cancers. Following one infection, similar to 47% of DCs overexpressed erbB2tr. To determine whether low doses of transduced DCs could protect mice from prostate cancer cells, we performed prime/boost...


Source: Vaccine Weekly (2008-05-28)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login